GREY:NEPTF - Post by User
Comment by
dqmaon Nov 21, 2010 10:01am
354 Views
Post# 17735719
RE: Where's the AHA coverage?
RE: Where's the AHA coverage?the safety is still a question mark with anacetrapib, the merck drug that is closely associated with the failed pfizer drug torcetrapib.
https://www.bloomberg.com/news/2010-11-17/merck-drug-improves-cholesterol-without-safety-risk-of-pfizer-s-product.html
Torcetrapib increased the number of deaths in its finalstudy, making that a key issue, said Harlan Krumholz, acardiologist and professor at Yale University School ofMedicine. In Merck study today, four patients taking anacetrapiband one person given a placebo died from cardiovascular causes.While the difference could have stemmed from chance, it issomething to watch, he said.
“I’m not saying this will be a dangerous drug, but I’m notsure there will be reduction in deaths,” he said in aninterview. “I’m bullish on the idea of testing this, I’m justnot bullish about the result. I don’t have enough information.”